Search - tctmd.com

Displaying 221 - 240 of 389

Sort: Relevancy | Date

Presentation TCT 2017

RAPID Program: Industry View

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Robert Thatcher

October 30, 2017

Presentation TCT 2017

RAPID Program: Academic View

Presenter: Schuyler Jones, Hiroyoshi Yokoi

October 30, 2017

Presentation TCT 2017

RAPID Program: PMDA View

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Yoshimasa Yokoyama

October 30, 2017

Presentation TCT 2017

Registry Assessment of Peripheral Interventional Devices (RAPID) Program

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Eleni Whatley

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

Presentation TCT 2017

Should Alleviating ISCHEMIA Be the Goal?

Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno

October 30, 2017

Presentation TCT 2017

Is Endovascular Intervention the First-line Therapy for Patients With Critical Limb Ischemia?

Presenter: Masato Nakamura, Shigeru Saito, Osamu Iida

October 29, 2017

Presentation TCT 2016

Case Presentation: BTK Intervention in Critical Limb Ischemia

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Zaza Kavteladze

November 01, 2016

Presentation TCT 2016

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Presenter: John A. Ambrose, Peter H. Stone

November 01, 2016

Presentation TCT 2016

Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and Midterm Results of the PACUS Trial

Presenter: Michael D. Dake, Kenneth Rosenfield, Costantino Del Giudice

November 01, 2016

News Conference News TCT 2016

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical Limb Center

Presenter: George L Adams, John F Angle, Raghu Kolluri

October 31, 2016

Presentation TCT 2016

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

Presenter: Justin E. Davies, Ran Kornowski, Colin Berry

October 31, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

News Conference News TCT 2016

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Michael H. Wilson

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Presenter: Ran Kornowski, Michel R. Le May, Anthony H. Gershlick

October 31, 2016

Presentation TCT 2016

TCT 18: Validation of Wound, Ischemia, Foot Ischemia (WIFI) classification System in Japanese Patients After Endovascular Treatment for Critical Limb Ischemia (CLI).

Presenter: Sriram S. Iyer, Craig M. Walker, Takahiro Tokuda

October 31, 2016

News Conference News TCT 2016

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

TCT Daily Staff

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Bernard J. Gersh

October 30, 2016

Advertisement

RAPID Program: Industry View

RAPID Program: Academic View

RAPID Program: PMDA View

Registry Assessment of Peripheral Interventional Devices (RAPID) Program

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Should Alleviating ISCHEMIA Be the Goal?

Is Endovascular Intervention the First-line Therapy for Patients With Critical Limb Ischemia?

Case Presentation: BTK Intervention in Critical Limb Ischemia

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and Midterm Results of the PACUS Trial

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical Limb Center

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

TCT 18: Validation of Wound, Ischemia, Foot Ischemia (WIFI) classification System in Japanese Patients After Endovascular Treatment for Critical Limb Ischemia (CLI).

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content